Can a sound biological mechanism compensate for poor manufacturing quality?

Understanding the question

No. A mechanism describes what a defined intervention might do, while manufacturing determines what people actually receive. Biological products can vary in identity, purity, potency, contaminants, and structural characteristics. Those differences may change effectiveness or create safety problems even if the intended target is scientifically reasonable. Quality assessment therefore needs validated processes, appropriate testing, and traceability between the material used in experiments and the material used clinically. A label, a chemical name, or a purity claim does not establish that an experimental biological preparation has the characteristics required for safe human use.

What a useful investigation needs to consider

Purity is not a complete quality specification. A preparation can appear chemically pure while having unsuitable biological activity, microbial contamination, unexpected aggregates, or a different composition from the material studied in a trial.

Changes in manufacturing can change the product. Comparability assessments examine whether a new process preserves relevant quality attributes and whether additional biological or clinical evidence is needed.

Independent testing is only meaningful within its scope. A certificate should identify the material, method, tested attributes, and limitations; it cannot substitute for an evaluated clinical product or establish suitability for self-administration.

Read the detailed explanation

The companion article explores manufacturing quality is part of biological safety in more depth, with topic-specific explanations and source material.